Top Markets
Coin of the day
Immuno-Biological Laboratories Co., Ltd. Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.

4570
株式のランク #24051
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to... Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
株価
$7.05
最終同期: 2026-08-21
時価総額
$65.63M
変化(1日)
-1.64%
変化(1年)
117.11%
JP
取引 Immuno-Biological Laboratories Co., Ltd. (4570)

カテゴリー

Immuno-Biological Laboratories Co., Ltd.(4570)のP/S比率
2026 時点のP/S比率 TTM: 0
Immuno-Biological Laboratories Co., Ltd. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Immuno-Biological Laboratories Co., Ltd. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH